Dr. med. Veronika Bahlinger

Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie Institute of Pathology

Heterogeneity-analysis of molecular subtypes of muscle-invasive bladder cancer and their precursor lesions in multiregion mapped whole-organ bladders (2020) Weyerer V, Lange F, Wullweber A, Stöhr R, Bertz S, Wach S, Taubert H, et al. Conference contribution TFE3 activation in a TSC1-altered malignant PEComa: challenging the dichotomy of the underlying pathogenic mechanisms (2020) Schmiester M, Dolnik A, Kornak U, Pfitzner B, Hummel M, Treue D, Hartmann A, et al. Journal article Swi/snf alterations in squamous bladder cancers (2020) Achenbach F, Rose M, Ortiz-Brüchle N, Seillier L, Knüchel R, Weyerer V, Hartmann A, et al. Journal article Analysis of CXCL9, PD1 and PD-L1 mRNA in stage T1 non-muscle invasive bladder cancer and their association with prognosis (2020) Kubon J, Sikic D, Eckstein M, Weyerer V, Stöhr R, Neumann A, Keck B, et al. Journal article Uninflamed immunologic microenvironment of muscle-invasive bladder cancer associates with activating FGFR3 gene alterations. (2020) Weyerer V, Stöhr R, Strissel P, Strick R, Bolenz C, Hartmann A, Erben P, Eckstein M Conference contribution Sinonasal papillomas: A single centre experience on 137 cases with emphasis on malignant transformation and EGFR/KRAS status in “carcinoma ex papilloma” (2020) Maisch S, Müller SK, Traxdorf M, Weyerer V, Stoehr R, Iro H, Hartmann A, Agaimy A Journal article Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapy (2020) Eckstein M, Strissel P, Strick R, Weyerer V, Wirtz R, Pfannstiel C, Wullweber A, et al. Journal article CCL2 expression in tumor cells and tumor-infiltrating immune cells shows divergent prognostic potential for bladder cancer patients depending on lymph node stage (2020) Eckstein M, Epple E, Jung R, Weigelt K, Lieb V, Sikic D, Stöhr R, et al. Journal article FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical Cystectomy (2020) Sikic D, Eckstein M, Wirtz RM, Jarczyk J, Worst TS, Porubsky S, Keck B, et al. Journal article Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation (2020) Morsch R, Rose M, Maurer A, Cassataro MA, Braunschweig T, Knüchel R, Vögeli TA, et al. Journal article